🇺🇸 FDA
Patent

US 10626096

Azole derivatives as apelin receptor agonist

granted A61PA61P13/12A61P3/10

Quick answer

US patent 10626096 (Azole derivatives as apelin receptor agonist) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Grant date
Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P13/12, A61P3/10, A61P9/04, A61P9/10